INS and type 2 diabetes mellitus: The CIMT trial evaluated the effect of an 18-month treatment with metformin versus placebo and simultaneously the effect of three insulin analogue regimens on the progression of mean carotid intima media thickness in patients with type 2 diabetes [1].